The A disintegrin and metalloproteinase ADAM-10 and ADAM-17 can cleave B7–H6, a ligand for NKp30, from the surface of tumors, likely leading to reduced NKp30 expression on NK cells surrounding the tumor (93, 94). The gene discussed is NCR3; the disease is neoplasm.